Stock Track | Illumina Soars 5.28% Intraday as Q2 Earnings Beat Spurs Bullish Reaction

Stock Track

Jul 31

Shares of Illumina (ILMN) surged 5.28% during intraday trading on Thursday, following the release of the company's second fiscal quarter earnings report after the previous day's close.

The positive market reaction came as Illumina posted another quarter of above-consensus results, extending a streak of strong performance. The company's recent track record includes a 9.52% EPS beat in Q1, a 10.2% beat in Q4, and a full-year revenue guidance range that topped analyst estimates. Additionally, the board authorized a $1.5 billion stock buyback program, further boosting investor confidence.

Analyst sentiment has grown increasingly bullish, with firms like JPMorgan and Daiwa Securities issuing upgrades in recent months. RBC highlighted that the company's mid-teens clinical growth, driven by oncology testing and screening applications, appears sustainable over the next one to two years, reinforcing the optimistic outlook for the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1163661577"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163661577\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163661577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 03:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163661577","market":"nz","top_or_hot":-1,"title":"Stock Track | Illumina Soars 5.28% Intraday as Q2 Earnings Beat Spurs Bullish Reaction","media":"Stock Track","content":"<p>Shares of Illumina (ILMN) surged 5.28% during intraday trading on Thursday, following the release of the company's second fiscal quarter earnings report after the previous day's close.</p><p>The positive market reaction came as Illumina posted another quarter of above-consensus results, extending a streak of strong performance. The company's recent track record includes a 9.52% EPS beat in Q1, a 10.2% beat in Q4, and a full-year revenue guidance range that topped analyst estimates. Additionally, the board authorized a $1.5 billion stock buyback program, further boosting investor confidence.</p><p>Analyst sentiment has grown increasingly bullish, with firms like JPMorgan and Daiwa Securities issuing upgrades in recent months. RBC highlighted that the company's mid-teens clinical growth, driven by oncology testing and screening applications, appears sustainable over the next one to two years, reinforcing the optimistic outlook for the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Illumina Soars 5.28% Intraday as Q2 Earnings Beat Spurs Bullish Reaction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Illumina Soars 5.28% Intraday as Q2 Earnings Beat Spurs Bullish Reaction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-31 03:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Illumina (ILMN) surged 5.28% during intraday trading on Thursday, following the release of the company's second fiscal quarter earnings report after the previous day's close.</p><p>The positive market reaction came as Illumina posted another quarter of above-consensus results, extending a streak of strong performance. The company's recent track record includes a 9.52% EPS beat in Q1, a 10.2% beat in Q4, and a full-year revenue guidance range that topped analyst estimates. Additionally, the board authorized a $1.5 billion stock buyback program, further boosting investor confidence.</p><p>Analyst sentiment has grown increasingly bullish, with firms like JPMorgan and Daiwa Securities issuing upgrades in recent months. RBC highlighted that the company's mid-teens clinical growth, driven by oncology testing and screening applications, appears sustainable over the next one to two years, reinforcing the optimistic outlook for the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ILMN","symbol_name":"Illumina","start_time":0,"source_url":"","article_id":"1163661577","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163661577","pubTimestamp":1785441384,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Illumina (ILMN) surged 5.28% during intraday trading on Thursday, following the release of the company's second fiscal quarter earnings report after the previous day's close.The positive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ILMN":"Illumina"},"translate_title":"股票跟踪 | Illumina 第二季度盈利超出预期，引发看涨反应，盘中飙升 5.28%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ILMN":1},"content_text":"Shares of Illumina (ILMN) surged 5.28% during intraday trading on Thursday, following the release of the company's second fiscal quarter earnings report after the previous day's close.The positive market reaction came as Illumina posted another quarter of above-consensus results, extending a streak of strong performance. The company's recent track record includes a 9.52% EPS beat in Q1, a 10.2% beat in Q4, and a full-year revenue guidance range that topped analyst estimates. Additionally, the board authorized a $1.5 billion stock buyback program, further boosting investor confidence.Analyst sentiment has grown increasingly bullish, with firms like JPMorgan and Daiwa Securities issuing upgrades in recent months. RBC highlighted that the company's mid-teens clinical growth, driven by oncology testing and screening applications, appears sustainable over the next one to two years, reinforcing the optimistic outlook for the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}